We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
Cap. Flow
-$355M
Cap. Flow %
-11.42%
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$28.9M
2
CVS icon
CVS Health
CVS
+$27.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$25M
4
UNH icon
UnitedHealth
UNH
+$20.4M
5
CRM icon
Salesforce
CRM
+$18.8M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$43.8M
2
EWJ icon
iShares MSCI Japan ETF
EWJ
+$42.6M
3
KO icon
Coca-Cola
KO
+$40M
4
ILMN icon
Illumina
ILMN
+$31.6M
5
HAIN icon
Hain Celestial
HAIN
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 17.53%
3 Consumer Discretionary 16.73%
4 Industrials 11.77%
5 Energy 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBLY
26
DELISTED
Mobileye N.V.
MBLY
$33.2M 1.07%
730,220
+188,820
+35% +$10.4M
JBHT icon
27
JB Hunt Transport Services
JBHT
$25.6B
$31.9M 1.03%
447,020
+228,540
+105% +$18.1M
COP icon
28
ConocoPhillips
COP
$170B
$31.8M 1.02%
664,062
+139,800
+27% +$7.11M
ULTA icon
29
Ulta Beauty
ULTA
$23.3B
$31.2M 1%
191,080
+175,580
+1,133% +$28.9M
WSM icon
30
Williams-Sonoma
WSM
$26.1B
$28.7M 0.92%
751,060
+243,640
+48% +$9.92M
EOG icon
31
EOG Resources
EOG
$80.6B
$28.1M 0.9%
385,605
+126,160
+49% +$9.8M
MDVN
32
DELISTED
MEDIVATION, INC.
MDVN
$26.2M 0.84%
617,040
+263,780
+75% +$13.1M
CHRW icon
33
C.H. Robinson
CHRW
$18.4B
$25.2M 0.81%
371,192
+59,030
+19% +$3.96M
CBRE icon
34
CBRE Group
CBRE
$40.6B
$23.6M 0.76%
736,212
+93,500
+15% +$3.32M
BMY icon
35
Bristol-Myers Squibb
BMY
$130B
$23.3M 0.75%
+393,310
New +$25M
HBI
36
DELISTED
Hanesbrands
HBI
$23.1M 0.74%
797,040
-840,380
-51% -$26M
AMSG
37
DELISTED
Amsurg Corp
AMSG
$21.5M 0.69%
276,345
-12,320
-4% -$950K
LGND icon
38
Ligand Pharmaceuticals
LGND
$5.52B
$18M 0.58%
336,608
-15,283
-4% -$927K
LEN icon
39
Lennar Class A
LEN
$19.3B
$17.9M 0.58%
390,283
– –
ZD icon
40
Ziff Davis
ZD
$2.03B
$17.7M 0.57%
287,066
+28,325
+11% +$1.72M
NFLX icon
41
Netflix
NFLX
$324B
$17.7M 0.57%
1,709,800
+624,800
+58% +$6.71M
ADBE icon
42
Adobe
ADBE
$102B
$17.6M 0.57%
+214,400
New +$17.4M
PCAR icon
43
PACCAR
PCAR
$64.5B
$17M 0.55%
488,415
-19,650
-4% -$796K
ACHC icon
44
Acadia Healthcare
ACHC
$2.55B
$16.4M 0.53%
247,118
-12,536
-5% -$964K
ABMD
45
DELISTED
Abiomed Inc
ABMD
$16.2M 0.52%
174,681
-59,194
-25% -$5.22M
SSNC icon
46
SS&C Technologies
SSNC
$19.1B
$16M 0.52%
457,222
+12,322
+3% +$416K
HELE icon
47
Helen of Troy
HELE
$628M
$15.7M 0.5%
175,642
+4,283
+2% +$384K
PENN icon
48
PENN Entertainment
PENN
$2.38B
$15.3M 0.49%
914,305
-41,159
-4% -$752K
ALR
49
DELISTED
Alere Inc
ALR
$15.3M 0.49%
316,847
-14,321
-4% -$742K
TYL icon
50
Tyler Technologies
TYL
$14.5B
$15.2M 0.49%
101,589
-4,563
-4% -$641K
1
2
3 4 5

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q3 2015 Portfolio in Review

As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.

  • Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
  • Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
  • Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
  • Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
  • Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
  • Castleark Management opened 67 new positions and closed 71 in Q3 2015.
  • Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.

Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.